Hologic, Inc. (HOLX.OB) Reports Second Quarter Revenue of $431 Million – Yet Stock Plunge
Hologic, Inc. (HOLX.OB), a diversified medical technologies company specializing in diagnostics, imaging systems and interventional devices dedicated to serving the healthcare needs of women, recently reported the company’s second quarter earnings. The company reported second quarter revenue of $431 million, a 138% year-over-year increase when compared to revenues of $181.1 million in the second quarter of 2007. The dramatic increase, however, is mostly due to the inclusion of approximately $189.2 million of revenues from the merger with Cytyc Corporation on October 22, 2007. For the second quarter of 2008, Hologic reported net income of $56 million, or $0.22 per diluted…